Premium
Maternal complications after Caesarean section in HIV‐infected pregnant women
Author(s) -
Panburana Panyu,
Phaupradit Winit,
Tantisirin Orathai,
Sriintravanit Narumon,
Buamuenvai Jerdjai
Publication year - 2003
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1046/j.0004-8666.2003.00027.x
Subject(s) - medicine , zidovudine , caesarean section , gestation , nevirapine , obstetrics , pregnancy , lamivudine , human immunodeficiency virus (hiv) , gynecology , viral disease , viral load , antiretroviral therapy , hepatitis b virus , virus , family medicine , virology , biology , genetics
A study of maternal complications after elective Caesarean section in HIV‐infected women was carried out from January 1999 to April 2001. The control group consisted of all the seronegative pregnant women who underwent the elective Caesarean section during the study period. The study group was divided into two subgroups. Subgroup 1 patients were given 600 mg zidovudine (ZDV) orally and 300 mg lamivudine (3TC) daily from 34 to 38 weeks’ gestation. Subgroup 2 patients were given 600 mg ZDV orally daily from 34 to 38 weeks’ gestation and 150 mg nevirapine orally on the morning of the Caesarean section day. In both groups, the elective Caesarean section was carried out at 38 weeks’ gestation and ZDV syrup (2 mg/kg) was given orally to the newborn immediately in the operating theatre and then every 6 h for 4 weeks. No statistically significant differences in maternal complications were found between the HIV‐infected and non HIV‐infected women.